Advanced search
Publication Cover
Hematology Volume 13, 2008 - Issue 2
Submit an article Journal homepage
238
Views
8
CrossRef citations to date
0
Altmetric
Hematological Malignancy: Malignant lymphoma

Modified IDARAM chemotherapy regimen for primary central nervous system lymphoma: experience of three cases

Mehmet YilmazDepartment of Hematology, Gaziantep University Medical School, Gaziantep, Turkey
,
Ibrahim ErkutluDepartment of Neurosurgery, Gaziantep University Medical School, Gaziantep, Turkey
,
Sevil KilciksızDepartment of Radiation Oncology, Gaziantep University Medical School, Gaziantep, Turkey
,
Mustafa PehlivanDepartment of Hematology, Gaziantep University Medical School, Gaziantep, Turkey
,
Vahap OkanDepartment of Hematology, Gaziantep University Medical School, Gaziantep, Turkey
,
Mehmet AlptekinDepartment of Neurosurgery, Gaziantep University Medical School, Gaziantep, Turkey
&
Ibrahim SariDepartment of Pathology, Gaziantep University Medical School, Gaziantep, Turkey
 show all
Pages 107-113 | Published online: 18 Jul 2013

Citations (8)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Lois A. Lampson. (2011) Monoclonal antibodies in neuro-oncology. mAbs 3:2, pages 153-160.
Read now

Articles from other publishers (7)

Senem Maral, Murat Albayrak, Cigdem Pala, Abdulkerim Yıldız, Hacer B Ozturk & Osman Sahin. (2021) R-IDARAM treatment in central nervous system lymphomas: a single-center experience and review of the literature. Avicenna Journal of Medicine 10:04, pages 227-231.
Crossref
Ni Fan, Lu Zhang, Xiaoping Xu, Bobin Chen, Chen Zhu, Pei Li, Zi Chen, Tianling Ding, Yan Ma, Yan Yuan & Zhiguang Lin. (2017) Methotrexate plus idarubicin improves outcome of patients with primary central nervous system lymphoma. Oncotarget 8:32, pages 53701-53713.
Crossref
Liren QianCiprian TomuleasaIoan-Alexandru FlorianJianliang ShenIoan-Stefan FlorianMihnea ZdrengheaDelia Dima. (2017) Advances in the treatment of newly diagnosed primary central nervous system lymphomas. Blood Research 52:3, pages 159.
Crossref
Liren Qian, Chunhui Zhou, Jianliang Shen, Jian Cen & Wenjie Yin. (2016) Treatment of newly diagnosed B-cell origin primary CNS lymphoma with systemic R-IDARAM chemotherapy and intrathecal immunochemotherapy. Oncotarget 7:18, pages 25783-25790.
Crossref
Gaelle Olivier, Aline Clavert, Laurence Lacotte-Thierry, Martine Gardembas, Martine Escoffre-Barbe, Annie Brion, Isabelle Cumin, Eric Legouffe, Philippe Solal-Celigny, Michèle Chabin, Pierre Ingrand, Philippe Colombat & Vincent Delwail. (2014) A phase 1 dose escalation study of idarubicin combined with methotrexate, vindesine, and prednisolone for untreated elderly patients with primary central nervous system lymphoma: The GOELAMS LCP 99 trial. American Journal of Hematology 89:11, pages 1024-1029.
Crossref
Defeng Zhao, Liren Qian, Jianliang Shen, Xiaopeng Liu, Ke Mei, Jian Cen, Yaming Wang, Congyong Li & Yuanyuan Ma. (2014) Combined treatment of rituximab, idarubicin, dexamethasone, cytarabine, methotrexate with radiotherapy for primary central nervous system lymphoma. Journal of Cellular and Molecular Medicine 18:6, pages 1081-1086.
Crossref
Kennichi Taoka, Yasushi Okoshi, Noriaki Sakamoto, Shingo Takano, Akira Matsumura, Yuichi Hasegawa & Shigeru Chiba. (2010) A nonradiation-containing, intermediate-dose methotrexate regimen for elderly patients with primary central nervous system lymphoma. International Journal of Hematology 92:4, pages 617-623.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.